Gentian Diagnostics ASA (OSL:GENT)

Ligand Pharmaceuticals Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	80.25	84.74	87.64	81.6	114.94	157.99
Cash & Short-Term Investments	80.25	84.74	87.64	81.6	114.94	157.99
Cash Growth	-0.95%	-3.31%	7.41%	-29.00%	-27.25%	-7.74%
Accounts Receivable	24.4	23.29	11.57	10.06	6.51	7.63
Other Receivables	11.1	7.98	5.41	9.13	16.07	7.61
Receivables	35.5	31.28	16.98	19.19	22.58	15.24
Inventory	51.65	45.94	37.12	38.54	29.78	20.88
Other Current Assets	-	-0	-	0	-	-
Total Current Assets	167.4	161.96	141.73	139.33	167.3	194.1
Property, Plant & Equipment	11	14.02	18.05	21.64	19.49	25.55
Other Intangible Assets	31.52	28.46	21.16	26.82	25.01	-
Long-Term Deferred Tax Assets	21.29	25.23	-	-	-	-
Long-Term Deferred Charges	-	-	-	-	-	15.61
Other Long-Term Assets	-0	-	0.1	0	0	-0
Total Assets	231.2	229.66	181.04	187.79	211.79	235.27
Accounts Payable	30.59	6.55	3.71	4.44	4.98	5.81
Accrued Expenses	-	6.19	4.57	4.97	3.6	3.13
Current Portion of Leases	-	4.53	4.04	3.7	4.11	4.17
Other Current Liabilities	-	12.84	13	8.89	9.87	9.48
Total Current Liabilities	30.59	30.11	25.32	22	22.55	22.59
Long-Term Leases	3.15	5.51	9.01	11.62	14.47	18.1
Long-Term Deferred Tax Liabilities	-	-	0.07	-	-	-
Other Long-Term Liabilities	-	-0	-	-	-	-
Total Liabilities	33.75	35.61	34.4	33.62	37.02	40.69
Common Stock	1.54	1.54	1.54	1.54	1.54	1.54
Additional Paid-In Capital	317.34	314.72	312.14	309.1	305.75	300.55
Retained Earnings	-121.43	-122.21	-167.05	-156.48	-132.53	-107.51
Comprehensive Income & Other	-	0	0	0	0	-
Shareholders' Equity	197.46	194.05	146.64	154.17	174.77	194.58
Total Liabilities & Equity	231.2	229.66	181.04	187.79	211.79	235.27
Total Debt	3.15	10.04	13.05	15.32	18.58	22.28
Net Cash (Debt)	77.1	74.7	74.59	66.28	96.35	135.71
Net Cash Growth	5.25%	0.14%	12.55%	-31.21%	-29.00%	-18.71%
Net Cash Per Share	4.83	4.74	4.84	4.30	6.25	8.81
Filing Date Shares Outstanding	15.42	15.42	15.42	15.42	15.42	15.41
Total Common Shares Outstanding	15.42	15.42	15.42	15.42	15.42	15.41
Working Capital	136.8	131.85	116.41	117.34	144.74	171.52
Book Value Per Share	12.80	12.58	9.51	10.00	11.33	12.63
Tangible Book Value	165.94	165.59	125.48	127.35	149.76	194.58
Tangible Book Value Per Share	10.76	10.74	8.14	8.26	9.71	12.63
Machinery	-	-	-	-	-	11.51

Source: S&P Global Market Intelligence. Standard template. Financial Sources.